top of page

It's all Connected

Integrating Human Factors Engineering into Medical Device Design and its Impact on Reimbursement


This article delves into the intricate relationship between design development, human factors engineering, and reimbursement strategies in the context of medical devices. Beyond regulatory approval, the successful launch of a medical device requires a deep understanding of user interactions and a strategic reimbursement approach. This paper aims to elucidate the symbiotic nature of human factors engineering and reimbursement strategies, emphasizing their collective impact on a medical device's overall success in the market.

1. Introduction

1.1 Background

The medical device landscape is characterized by its complexities, with challenges ranging from stringent regulatory requirements to the dynamic nature of healthcare reimbursement. This article focuses on the pivotal roles played by design development and human factors engineering in shaping user-centric devices and subsequently influencing reimbursement strategies.

2. Design Development and Human Factors Engineering

2.1 Importance of Design in Medical Devices

Design is a cornerstone in the development of medical devices, influencing not only aesthetics but also functionality, safety, and user experience. Human factors need to be considered upfront as a main customer centric goal. These will then become part of the specifications for the device of which will ultimately be tested as part of the validation procedure.

2.2 Human Factors Engineering

Human factors engineering involves understanding how users interact with devices, aiming to optimize usability, reduce errors, and enhance overall user satisfaction.

2.3 Integration of Human Factors in the Design Process

Human factors should be integrated into each stage of the design process, from concept to post-market surveillance, to ensure a device aligns with user needs and expectations. The FDA requires this as part of the quality management system.

2.4 Usability Testing

Usability testing is a critical component, involving real-world scenarios to assess user interactions and identify areas for improvement in the design.

3. Reimbursement Strategies for Medical Devices

3.1 Reimbursement Landscape

Navigating the reimbursement landscape is challenging, with factors such as coding, coverage decisions, and payer policies significantly impacting a device's market success.

3.2 Coding and Coverage Considerations

Accurate coding and comprehensive coverage are essential for securing reimbursement approval, necessitating a proactive approach to align coding decisions with device functionality.  This will also impact how regulatory decisions are approached.  In the US the indications for use and intended use must be aligned with the CPT codes that are planning to be used for reimbursement.

3.3 Health Economic Outcomes Research

Health economic outcomes research plays a pivotal role in establishing the cost-effectiveness and value proposition of a medical device, influencing reimbursement decisions.  For some devices this may not be necessary as there are other devices that have already shown the health economic benefits and CPT codes and reimbursement have been established.  However, if this is not the case, studies will have to be done to pursue reimbursement.  In the US this is a long and complex process to obtain a CPT code and obtain appropriate reimbursement.  Typical times can take 5 or more years.

3.4 Payer Engagement Strategies

Engaging with payers early in the development process is crucial, fostering a shared understanding of the device's benefits and facilitating a smoother reimbursement pathway.  Often times private payers may reimburse before CPT category 1 codes are issued.  This can have two major impacts.  One is getting reimbursement at least in a particular area with particular payers.  The other is that it can then put more pressure on establishing CPT category 1 codes.

4. The Interplay between Human Factors and Reimbursement

4.1 Improved Outcomes and Reimbursement

Devices designed with a focus on human factors often contribute to improved patient outcomes, creating a favorable environment for reimbursement approval.  This seems simple and logical, but often times it is forgotten.  I’ve seen devices for positioning a patient, but when they were first designed they were designed for someone that is “average” height with no way of adapting for short or tall patients.  What about bariatric patients?  Is the device suitable for them?  One really has to question who is the device intended for and how to make it function for that patient population as best as possible.  That’s only one side of the equation, the other is the care provider.  Does it function for the surgeon (or other physician) as best as possible.  If someone is going to be in an operating room for a long procedure is the device suitable and comfortable to be used for that extended period? 

4.2 Aligning Design with Reimbursement Goals

Aligning design decisions with reimbursement goals requires collaboration between design teams and reimbursement strategists, emphasizing the need for an integrated approach.  Many companies forget to look at the reimbursement landscape before designing a device and then can often design a system that has no reimbursement.  If you can examine the reimbursement possibilities upfront and design in what is necessary this can make time to market and establishing a customer base far faster.

4.3 Case Studies

Exploring case studies provides practical insights into successful medical device launches where the integration of human factors positively influenced reimbursement outcomes.  No matter what the reimbursement landscape is this is almost always necessary.  If for nothing more publications and presentations at national conferences can establish the validity of the device that has been developed. 

5. Future Directions and Recommendations

5.1 Emerging Trends

As the healthcare landscape evolves, emerging trends such as digital health and value-based care will further impact the integration of human factors and reimbursement strategies.  AI is playing a major role in healthcare and most companies are gravitating towards using it in some form or fashion.  And while the acceleration of AI in healthcare is greater than ever before, AI is not new to healthcare.  In the 1990’s R2 developed the first AI algorithm to detect breast cancer.  They were ultimately bought by Hologic and while the technology has advanced considerably the basic foundation of R2’s work is still employed.

5.2 Recommendations for Stakeholders

Stakeholders, including developers, regulators, and payers, should collaborate to enhance the integration of human factors engineering and reimbursement strategies. Early planning, open communication, and a shared commitment to patient-centric outcomes are crucial.  In the US this is difficult as the regulatory process is separate from the reimbursement process.  However, early conversations with the FDA and close examination of the reimbursement landscape will pay dividends down the road.

6. Conclusion

In conclusion, the interconnected nature of design development, human factors engineering, and reimbursement strategies is evident in the success of medical device launches. A holistic approach that prioritizes user-centric design and aligns with reimbursement goals is essential for navigating the complexities of the healthcare industry and ensuring the success of medical devices in the market. This article serves as a guide for stakeholders, offering insights and recommendations for optimizing this intricate relationship.



bottom of page